Goldman Sachs’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-12,800
Closed -$181K 6574
2026
Q1
$181K Buy
+12,800
New +$189K ﹤0.01% 6110
2023
Q4
Sell
-49,190
Closed -$713K 5622
2023
Q3
$713K Buy
+49,190
New +$736K ﹤0.01% 4468

Other funds holding BCAT

Goldman Sachs's BCAT Position: Q2 2026 in Review

Goldman Sachs sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q2 2026, closing a stake of 12,800 shares — an estimated $181K sold.

Goldman Sachs first reported a position in BCAT in Q3 2023 and held it in 2 quarters. The position peaked at $713K in Q3 2023. 110 funds tracked by Wall St. Rank hold BCAT as of Q2 2026.

  • Goldman Sachs reported no remaining BlackRock Capital Allocation Term Trust position as of Q2 2026 after selling out during the quarter.
  • Goldman Sachs sold 12,800 BlackRock Capital Allocation Term Trust shares in Q2 2026, an estimated $181K.
  • Goldman Sachs first reported a position in BlackRock Capital Allocation Term Trust in Q3 2023 and held it in 2 quarters.
  • Goldman Sachs's BlackRock Capital Allocation Term Trust position peaked at $713K in Q3 2023.
  • 110 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.